ProCE Banner Activity

HPTN 083 Case Series: Treatment Outcomes Among People Who Acquired HIV During LA CAB PrEP

Conference Coverage
Slideset

In this series of 47 participants who acquired HIV during pre-exposure prophylaxis with long-acting cabotegravir in the HPTN 083 study, short-term treatment outcomes were similar with INSTI-based antiretroviral therapy (ART) and other (PI-based) ART regimens.

Released: March 18, 2025

Expiration: September 17, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare